Altre lingue ImpediMed Limited

Azioni

Tempo differito Australian S.E. Altri mercati azionari 08:10:52 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,09 ^AUD	0,00%		-4,26%	-37,93%

17/04	IMPEDIMED LIMITED : giudizio positivo da Ord Minnet	ZM
11/04	ImpediMed presenterà i risultati dello studio sul linfedema cronico correlato al cancro al seno al Meeting annuale della Società Americana dei Chirurghi del Seno	CI

Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	17/04
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	11/04
ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index	18/03
Impedimed Names Independent Non-Executive Chair	27/02
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	27/02
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	14/02
ImpediMed CEO, CFO Step Down; Shares Fall 11%	20/11
ImpediMed Limited Announces CEO Changes	19/11
ImpediMed Limited Announces CFO Changes	19/11
ImpediMed Limited Announces Management Changes	19/11
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	03/11
Morgans rates IPD as Add	01/11
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03/10/23
Impedimed Limited Announces Board Changes	28/09/23
Declaration of Voting Results by ImpediMed Limited	28/09/23
ImpediMed Appoints Medical Chief; Shares Down 3%	27/09/23
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	27/09/23
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	31/08/23
ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23

Non ci sono risultati per questa ricerca